Nymox Pharmaceutical Corporation NYMXF
0.02 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
0.02 Day range 0.02
0.0002 52-week range 0.1999
- YTD
- -50.25%
- 1 year
- -77.78%
News
accessnewswire.com NYMOX Provides Current Update IRVINE, CA / ACCESS Newswire / June 2, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) reports that its plans for Nymozarfex (TM) are currently focused on re-submission…
accessnewswire.com NYMOX Provides Recent Updates IRVINE, CA / ACCESS Newswire / March 27, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) will be shortly updating the Board of Directors. Patrick Doody has retired from…
globenewswire.com Nymox Announces Dismissal of Delaware Action Against Ascella IRVINE, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Nymox announces that it dismissed the Delaware matter pending against Ascella on March 7, 2025. A number of factors caused the company to reconsider…
globenewswire.com NYMOX Announces Trading Resumed and New Listing on OTCQB Market IRVINE Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that the Company's stock has resumed trading under the symbol NYMXF on…
globenewswire.com Nymox Announces Filing of Annual Report IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) is pleased to report that it filed its Annual Report with the Security and Exchange…
globenewswire.com Nymox Annual Report IRVINE, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that its Annual Report is and has been in progress since late…
globenewswire.com Nymox Required to Resubmit Application to DKMA IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that its MAA submission to the Danish Medicines Agency (DKMA) has run…
globenewswire.com Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages IRVINE, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets - NYMXF) is pleased to report that the Bahamas Supreme Court has issued a formal Order…
globenewswire.com Nymox December 27 Message to Shareholders IRVINE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) is pleased to provide this end-of-the year message to shareholders.
globenewswire.com Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others IRVINE, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that the California Superior Court, Orange County (OCSC) has issued an…
globenewswire.com $250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court IRVINE, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that the California Superior Court, Orange County (OCSC) has accepted…
globenewswire.com Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- This week, Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets - NYMXF) was forced to file a lawsuit in California Superior Court, Orange County,…
globenewswire.com NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized IRVINE, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox” or the “Company”) [OTC Markets---NYMXF] is pleased to announce that the Bahamian Court (Senior Justice…
globenewswire.com NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023 Ex-Employees and Agents, and those working in concert with them, are ordered by a California Court to stop using, disclosing, relying on, or otherwise make publicly available Nymox privileged…
globenewswire.com IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations IRVINE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- The following is Nymox's response to an unauthorized shareholder meeting: Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company” or…
globenewswire.com IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting IRVINE Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- The following is Nymox's response to an unauthorized shareholder meeting: Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company” or…
globenewswire.com Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting IRVINE, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) -- The following is Nymox's response to an unauthorized shareholder meeting: Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”)…
globenewswire.com Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review IRVINE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) is pleased to announce that the Company's recent submission of Fexapotide…
businesswire.com The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting CARSON CITY, Nev. & LONDON--(BUSINESS WIRE)--THE COMMITTEE TO RESTORE NYMOX SHAREHOLDER VALUE SENDS LETTER TO NYMOX PHARMACEUTICAL SHAREHOLDERS.
globenewswire.com Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) is pleased to announce today that a new formal submission has been made by…